Alpha 2.0
Login Register
» Articles » PMID: 27217452

Appraising the Biological Evidence for and Against the Utility of GnRHa for Preservation of Fertility in Patients With Cancer

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2016 May 25
PMID 27217452
Citations 13
Authors
Kutluk Oktay
Giuliano Bedoschi
Affiliations
Soon will be listed here.
Citing Articles

Fertility Preservation and Ovarian Hyperstimulation Syndrome Management in Cancer Care: A Pathophysiological Perspective on Gonadotropin-Releasing Hormone Agonists and Antagonists.

Bedoschi G, Ingold C, Navarro P Pathophysiology. 2024; 31(2):288-297.

PMID: 38921726 PMC: 11206524. DOI: 10.3390/pathophysiology31020021.

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.

Ingold C, Navarro P, de Oliveira R, Barbosa C, Bedoschi G Ther Adv Reprod Health. 2023; 17:26334941231196545.

PMID: 37674690 PMC: 10478554. DOI: 10.1177/26334941231196545.

Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases.

Wang Z, An J, Wang C BMC Womens Health. 2022; 22(1):436.

PMID: 36345026 PMC: 9641837. DOI: 10.1186/s12905-022-02039-8.

The Experience of Fertility Preservation in a Single Tertiary Center in Korea.

Choi Y, Hong Y, Kim S, Kim S, Lee J, Suh C Front Endocrinol (Lausanne). 2022; 13:845051.

PMID: 35518927 PMC: 9062070. DOI: 10.3389/fendo.2022.845051.

Artificial Ovary for Young Female Breast Cancer Patients.

Chen J, Torres-de la Roche L, Kahlert U, Isachenko V, Huang H, Hennefrund J Front Med (Lausanne). 2022; 9:837022.

PMID: 35372399 PMC: 8969104. DOI: 10.3389/fmed.2022.837022.